Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at ...

Data Demonstrate Potential for Differentiated Efficacy and Safety Profile, Including Complete Responses as Monotherapy in Multiple CDX and PDX ...
Taiwan News

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at ...

PRT13722 has an improved preclinical hematological safety profile compared to prifetrastat, which may enable combinations with standard of care agents in HR+ BC. PRT13722 is on track for IND filing in ...
Analytics Insight

Breaking: ED Intensifies Crypto Theft Investigation, Raids Bengaluru Sites Linked to Congress MLA’s Sons

The Enforcement Directorate conducted multiple raids across Bengaluru on April 20. The locations were allegedly linked to the ...

Court grants time to ED to file reply on Jacqueline's plea; ED calls it 'Vague'

The Patiala house court in the national capital on Monday granted time to the Enforcement Directorate (ED) to file its reply on Bollywood Actor Jacqueline Fernandes's application for turning approver ...
Asianet Newsable on MSN

Jacqueline's approver plea: Court gives ED time to reply on application

A Delhi court has granted the Enforcement Directorate (ED) time until May 8 to file a reply on Jacqueline Fernandes's plea to ...